# Acuity Brands (AYI) — Financial Analysis

**Exchange:**   
**Coverage as of:** 2026-Q2  
**Updated:** 2026-06-10  
**Tier:** Free primer (step 2 of 19)  
**Sibling pages:** /stocks/AYI/thesis · /stocks/AYI/memo

## Financial Snapshot

---
source: coverage-next-full
ticker: AYI
company: Acuity Inc.
step: "04"
title: Financial Quality & Adversarial Sweep
generated: 2026-06-10
---

### Step 04 — Financial Quality & Adversarial Sweep: Acuity Inc. (AYI)

#### 1. Executive Summary

AYI's financial statements are of high quality. The company is a clean US filer with consistent GAAP reporting, regular SEC oversight, and a clear audit trail. The primary GAAP complexity is the growing GAAP vs. adjusted EPS gap ($5.47/shr in FY2025) driven by intangible amortization from acquisitions (primarily QSC). The adversarial sweep found no material accounting concerns, short reports, or ongoing litigation of significance. The main legitimate bear concern is valuation-related (multiple re-rating risk), not accounting-related.

#### 2. Statement Quality Assessment

##### Income Statement

| Item | Assessment | Notes |
|------|-----------|-------|
| Revenue recognition | Clean | ASC 606 adopted; contract assets disclosed |
| Non-GAAP adjustments | Material but disclosed | $5.47/shr gap FY2025; all line items disclosed in earnings releases |
| Special charges | Recurring in nature | ABL restructuring charges every 1-2 years; appropriately categorized |
| SBC expensing | Proportionate | 0.8-1.2% of revenue; standard for industrial company |

**Primary adjustment items (FY2025):**
- Acquired intangible amortization (QSC + prior acquisitions): est. ~$65-80M/yr pre-tax
- Restructuring/special charges: $29.7M (Q3 FY2025 ABL) + $5.9M (Q2 FY2026 ABL)
- Pension settlement charge: $30.9M non-cash (FY2025 Q4)
- One-time tax benefit: $8.2M (FY2025)
- Stock-based compensation: $46.6M (FY2024), est. ~$55M (FY2025 with QSC team)

**Assessment:** The non-GAAP adjustments are standard and disclosed. The Street appropriately uses adjusted EPS ($18.01 FY2025) as the primary metric. No evidence of aggressive revenue recognition or channel stuffing [Fact/S1, S3].

##### Balance Sheet

| Item | Assessment | Notes |
|------|-----------|-------|
| Goodwill & Intangibles | Growing; watch-list | $2.6B post-QSC (FY2025); ~55% of total assets |
| Inventory | Normal | $387.6M (FY2024) → $526.7M (FY2025); QSC-driven; turns healthy |
| Working capital | Strong | Current ratio 2.0x+ throughout history |
| Off-balance sheet | No material items found | Operating leases (ROU assets) per ASC 842; disclosed |
| Pension | Largely resolved | Pension obligation transferred to third party (Q4 FY2025 settlement) |

**Goodwill impairment risk:** $1,497M goodwill + $1,099M other intangibles = $2.6B total = ~57% of FY2025 total assets ($4,755M). The QSC acquisition added ~$400M goodwill + ~$620M intangibles at allocation. If QSC growth disappoints or margins compress materially, impairment risk is real. Management attributed no impairment risk as of last reporting [Judgment/S1].

##### Cash Flow

| Item | Assessment | Notes |
|------|-----------|-------|
| FCF quality | Excellent | FCF consistently ≥110% of GAAP net income |
| Working capital cycles | Normal | Seasonal Q1 trough (Nov fiscal quarter) typical |
| CapEx intensity | Very low | 1.4-1.7% of revenue; asset-light manufacturing |
| Acquisitions | Large FY2025 step-up | $1.215B QSC; investing CF $(1,281M) FY2025 |

**FCF conversion:** FY2024 FCF $555M on GAAP NI $423M = 131% FCF conversion — excellent. FCF demonstrates actual cash generation quality. [S1, S3]

#### 3. GAAP vs. Adjusted Reconciliation (FY2025)

| Metric | GAAP | Adjustment | Adjusted |
|--------|------|-----------|---------|
| EPS Diluted | $12.53 | +$5.47 | $18.01 |
| Operating Income | $563.9M | +$204.7M | $768.6M |
| Operating Margin | 13.0% | +4.7pp | 17.7% |

**Key adjustments (estimated):**
- Intangible amortization: ~+$65-80M pre-tax
- Restructuring/special charges: ~+$35-40M pre-tax
- Pension settlement: ~+$30.9M pre-tax
- Stock compensation: not added back (some peers do add back)
- Net: approximately ~$130-150M pre-tax adjustments in FY2025 [Estimate/S3, S10]

**Assessment:** The GAAP vs. adjusted gap is real-money cash (amortization is non-cash, buybacks are cash — EPS accretion from buybacks is real). The company's FCF more closely reflects economic reality than GAAP EPS. The adjusted EPS framework is standard for acquisition-heavy industrials [Judgment].

#### 4. Adversarial Research Sweep

*Note: No earnings transcripts available (coverage-next-full path). Adversarial sweep based on SEC filings, press reports, and public research.*

##### Short Reports / Critical Research

**Search result:** No publicly available short seller reports targeting AYI specifically were identified. AYI's relatively small float (~30M shares) and institutional ownership concentration (~98% institutional) make it a less common short target.

**Bear arguments found in public research (not short reports, but analyst concerns):**
1. **ABL structural decline:** Multiple analysts (Goldman Sachs downgrade to Neutral, April 2026) cite concern that ABL softness is structural, not cyclical
2. **Multiple re-rating risk:** At $380 peak (early 2026), stock traded ~28-29x adj. P/E — high for an industrial company
3. **QSC integration execution risk:** $1.215B acquisition for AIS; if organic AIS growth (ex-QSC) plateaus, growth narrative fails
4. **Pull-forward demand:** Q3 FY2025 order acceleration ahead of pricing — potential for demand air pocket in subsequent quarters

**Assessment:** These are legitimate investment risks but not accounting concerns. No evidence of fraudulent reporting, channel stuffing, or earnings manipulation. [S10]

##### Litigation and Legal

No material litigation identified in SEC filings or public research. Standard product liability disclosures in 10-K — not unusual for an industrial manufacturer.

##### Management Credibility

CEO Neil Ashe track record at Acuity (January 2020–):
- FY2020 (COVID year): Revenue -9.4%, Net Income -25% — legitimate macro headwind; no management manipulation
- FY2021–FY2024: Consistent margin expansion despite volume headwinds — ABS system demonstrable results
- Guidance accuracy: Consistent EPS beats; occasional revenue misses (FY2024 ABL, Q2 FY2026 revenue) — no pattern of sandbagging or misleading guidance
- QSC: Early integration results (8 months) ahead of plan — margins improved 500 bps vs. target

**Assessment:** Ashe's track record is credible. No red flags in guidance history or corporate actions [Judgment/S10].

##### GAAP vs. Adjusted Gap Audit

- $5.47/shr gap in FY2025 is large in percentage terms (~30% of GAAP EPS)
- However, the primary driver (intangible amortization) is non-cash and will decline over the QSC amortization schedule (typically 10-15 year useful life for customer relationships/trade names)
- Restructuring charges ($35-40M) are semi-recurring but disclosed; ABS-driven efficiency work justifies categorization as non-recurring
- No evidence of using adjusted EPS to mask deteriorating core economics — FCF independently confirms strong cash generation [Fact/S3]

#### 5. Financial Red Flags Assessment

| Flag | Present? | Comment |
|------|----------|---------|
| Revenue growth inconsistent with cash | No | FCF growth mirrors adjusted earnings growth |
| Accounts receivable growing faster than revenue | No | AR $563M → $594M with revenue +13%; proportionate |
| Inventory building without demand signal | Watch | Inventory up 36% (QSC addition); normalize for acquisition |
| Related party transactions | No | Standard board/compensation; no unusual RPTs in proxy |
| Auditor changes | No | Consistent major audit firm (Ernst & Young) |
| Frequent restatements | No | No restatements in recent history |
| Off-balance sheet debt | No | Operating leases properly disclosed per ASC 842 |

**Overall Financial Quality Rating: HIGH**

#### 6. Source Index

| ID | Source |
|----|--------|
| S1 | SEC XBRL / 10-K filings |
| S3 | StockAnalysis.com financial summary |
| S5 | GlobeNewswire Q2 FY2026 earnings release |
| S10 | Recent news and strategy research |

## Deeper Financial Analysis

The fundamental tier ($1.00) adds 8 dimensions not included here:

- Revenue Breakdown — segment revenue, geographic mix, product-line margins
- Financial Trends — QoQ momentum, leading indicators, inflection points
- Balance Sheet — debt structure, dilution risk, working capital dynamics
- Capital Allocation — ROIC, buyback cadence, reinvestment efficiency
- Earnings Analysis — beats/misses, guidance vs actuals, transcript highlights
- Competitive Positioning — market share, pricing power, peer benchmarks
- Industry Context — TAM, sector tailwinds/headwinds, regulatory backdrop

**API endpoint:** GET /api/v1/research/AYI/fundamental

## Navigation

- Overview: /stocks/AYI
- Financials (this page): /stocks/AYI/financials
- Thesis: /stocks/AYI/thesis
- Investment Memo: /stocks/AYI/memo
- Coverage universe: /stocks